KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Accounts Payables (2016 - 2025)

Fulgent Genetics (FLGT) has disclosed Accounts Payables for 11 consecutive years, with $18.7 million as the latest value for Q4 2025.

  • Quarterly Accounts Payables rose 1.58% to $18.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $18.7 million through Dec 2025, up 1.58% year-over-year, with the annual reading at $18.7 million for FY2025, 1.58% up from the prior year.
  • Accounts Payables hit $18.7 million in Q4 2025 for Fulgent Genetics, up from $18.1 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $37.1 million in Q2 2022 to a low of $14.5 million in Q3 2022.
  • Historically, Accounts Payables has averaged $20.1 million across 5 years, with a median of $19.3 million in 2024.
  • Biggest five-year swings in Accounts Payables: surged 510.86% in 2021 and later plummeted 44.47% in 2023.
  • Year by year, Accounts Payables stood at $20.5 million in 2021, then increased by 12.68% to $23.1 million in 2022, then plummeted by 33.49% to $15.4 million in 2023, then grew by 19.56% to $18.4 million in 2024, then increased by 1.58% to $18.7 million in 2025.
  • Business Quant data shows Accounts Payables for FLGT at $18.7 million in Q4 2025, $18.1 million in Q3 2025, and $18.9 million in Q2 2025.